These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs. Woggon B Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878 [TBL] [Abstract][Full Text] [Related]
45. Effect of rifampin on the plasma concentration and the clinical effect of haloperidol concomitantly administered to schizophrenic patients. Kim YH; Cha IJ; Shim JC; Shin JG; Yoon YR; Kim YK; Kim JI; Park GH; Jang IJ; Woo JI; Shin SG J Clin Psychopharmacol; 1996 Jun; 16(3):247-52. PubMed ID: 8784658 [TBL] [Abstract][Full Text] [Related]
46. Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients. Pan L; Vander Stichele R; Rosseel MT; Berlo JA; De Schepper N; Belpaire FM Ther Drug Monit; 1999 Oct; 21(5):489-97. PubMed ID: 10519444 [TBL] [Abstract][Full Text] [Related]
47. [Bromperidol decanoate in the residual phase of schizophrenia]. Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856 [TBL] [Abstract][Full Text] [Related]
48. Clinical efficacy, extrapyramidal symptoms and serum levels: influence of administration schedules and concomitant drugs on serum bromperidol concentrations. Fujii Y; Tateyama M; Kamisada M; Tanoue A; Takamiya M; Nakajima S; Itoh H Folia Psychiatr Neurol Jpn; 1984; 38(2):121-36. PubMed ID: 6152433 [TBL] [Abstract][Full Text] [Related]
51. A double-blind comparison of bromperidol and haloperidol in newly admitted schizophrenic patients. Brannen JO; McEvoy JP; Wilson WH; Petrie WM; Ban TA; Berney SA; Schaffer JD Pharmacopsychiatria; 1981 Jul; 14(4):139-40. PubMed ID: 6116246 [No Abstract] [Full Text] [Related]
52. Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia. Mihara K; Suzuki A; Kondo T; Yasui N; Furukori H; Nagashima U; Ono S; Kaneko S; Otani K; Inoue Y Ther Drug Monit; 2000 Jun; 22(3):245-9. PubMed ID: 10850389 [TBL] [Abstract][Full Text] [Related]
53. Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers. Madani S; Barilla D; Cramer J; Wang Y; Paul C J Clin Pharmacol; 2002 Nov; 42(11):1211-8. PubMed ID: 12412819 [TBL] [Abstract][Full Text] [Related]
54. An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects. Patroneva A; Connolly SM; Fatato P; Pedersen R; Jiang Q; Paul J; Guico-Pabia C; Isler JA; Burczynski ME; Nichols AI Drug Metab Dispos; 2008 Dec; 36(12):2484-91. PubMed ID: 18809731 [TBL] [Abstract][Full Text] [Related]
55. [Treatment with bromperidol in schizophrenic patients]. Ellerman LA Acta Psiquiatr Psicol Am Lat; 1988 Dec; 34(4):335-40. PubMed ID: 2908218 [TBL] [Abstract][Full Text] [Related]
56. Bromperidol decanoate (depot) for schizophrenia. Purgato M; Adams CE Cochrane Database Syst Rev; 2011 Sep; (9):CD001719. PubMed ID: 21901678 [TBL] [Abstract][Full Text] [Related]
57. Effects of itraconazole on the steady-state plasma concentrations of haloperidol and its reduced metabolite in schizophrenic patients: in vivo evidence of the involvement of CYP3A4 for haloperidol metabolism. Yasui N; Kondo T; Otani K; Furukori H; Mihara K; Suzuki A; Kaneko S; Inoue Y J Clin Psychopharmacol; 1999 Apr; 19(2):149-54. PubMed ID: 10211916 [TBL] [Abstract][Full Text] [Related]
58. Depot bromperidol decanoate for schizophrenia. Wong D; Adams CE; David A; Quraishi SN Cochrane Database Syst Rev; 2004; (3):CD001719. PubMed ID: 15266450 [TBL] [Abstract][Full Text] [Related]
59. Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes. Ono S; Mihara K; Suzuki A; Kondo T; Yasui-Furukori N; Furukori H; de Vries R; Kaneko S Psychopharmacology (Berl); 2002 Jun; 162(1):50-4. PubMed ID: 12107617 [TBL] [Abstract][Full Text] [Related]
60. Results of a clinical trial with bromperidol C-C 2489/21. Weiser G Acta Psychiatr Belg; 1978; 78(1):102-9. PubMed ID: 347873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]